ClinConnect ClinConnect Logo
Search / Trial NCT06598098

MAMA Tot - Healthy Weight Parallel Study

Launched by EAST CAROLINA UNIVERSITY · Sep 12, 2024

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Exercise Modes Exercise Intervention

ClinConnect Summary

The MAMA Tot - Healthy Weight Parallel Study is researching how different types of exercise during pregnancy can affect the health of both mothers and their babies. The study aims to find out whether aerobic exercise (like walking or swimming), resistance exercise (like weight training), or a combination of both can improve health outcomes for mothers and their infants compared to women who do not exercise during pregnancy. By involving 268 healthy pregnant women, the researchers will track the health of the mothers and their babies at different stages, specifically at 1, 6, and 12 months after birth.

To participate in this study, women must be between 18 and 40 years old, have a healthy weight (BMI between 18.5 and 24.4), and be less than 16 weeks pregnant with a single baby. They should also have clearance from their healthcare provider to exercise. Participants will be randomly assigned to different exercise groups or to a control group that does not exercise, and they will be monitored throughout their pregnancy and after their babies are born. This study is important because it could lead to better exercise recommendations for pregnant women, which may help improve health for future generations.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age: 18 to 40 years old
  • BMI 18.5 to 24.4
  • Pregnancy: Singleton; ≤ 16 weeks gestation
  • Clearance by Obstetric provider for exercise
  • Exclusion Criteria:
  • Age: ≤ 17.9 or ≥ 41 years of age
  • BMI ≥25
  • Multi fetal pregnancy
  • Obstetric Provider does not provide clearance for exercise
  • Unable or Unwilling to provide consent
  • Inability to communicate with members of study team, despite use of interpreter
  • Medical Conditions (e,g. HIV/Aids, Cancer, Type 1 or 2 Diabetes, Untreated Hypertension, Thyroid Disorders)
  • Use of tobacco products, alcohol, recreational drugs, or medications (oral hypertensive, insulin)
  • Unable to provide phone or email contact

About East Carolina University

East Carolina University (ECU) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, ECU leverages its diverse expertise in medicine, nursing, and public health to foster advancements in patient care. The university is committed to ethical practices and collaboration, ensuring rigorous methodologies and compliance with regulatory standards. By engaging in multidisciplinary approaches, ECU aims to contribute significantly to the understanding and treatment of various health conditions, ultimately enhancing health outcomes for diverse populations.

Locations

Greenville, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Linda May, MS, PhD

Principal Investigator

East Carolina University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported